Litcius/Paper detail

A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2

Liangqin Tong, Xiaoping Xiao, Min Li, Shisong Fang, Enhao Ma, Xi Yu, Yibin Zhu, Chunli Wu, Deyu Tian, Fan Yang, Jing Sun, Jing Qu, Nianzhen Zheng, Shumin Liao, Wanbo Tai, Shengyong Feng, Liming Zhang, Yuhan Li, Lin Wang, Xuelian Han, Shihui Sun, Long Yang, Hui Zhong, Jincun Zhao, Wenjun Liu, Xiaohui Liu, Penghua Wang, Liang Li, Guangyu Zhao, Renli Zhang, Gong Cheng

2022Nature Metabolism35 citationsDOIOpen Access PDF

Topics & Concepts

MetaboliteDiabetes mellitusCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PharmacologyChemistryInternal medicineMedicineEndocrinologyDiseaseInfectious disease (medical specialty)COVID-19 Clinical Research StudiesHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes and associated disorders
A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2 | Litcius